Purple Biotech Ltd. (PPBT)
PPBT Stock Price Chart
Explore Purple Biotech Ltd. interactive price chart. Choose custom timeframes to analyze PPBT price movements and trends.
PPBT Company Profile
Discover essential business fundamentals and corporate details for Purple Biotech Ltd. (PPBT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Nov 2015
Employees
9.00
Website
https://purple-biotech.comCEO
Michael Schickler
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel.
PPBT Financial Timeline
Browse a chronological timeline of Purple Biotech Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 May 2026
Upcoming earnings on 21 Nov 2025
EPS estimate is -$0.26.
Earnings released on 6 Aug 2025
EPS came in at -$0.40 falling short of the estimated -$0.21 by -90.48%.
Earnings released on 21 May 2025
EPS came in at -$0.17 .
Earnings released on 10 Mar 2025
EPS came in at -$0.26 falling short of the estimated -$0.22 by -18.18%.
Earnings released on 15 Nov 2024
EPS came in at -$1.37 falling short of the estimated -$1.20 by -14.17%.
Stock split effective on 17 Sept 2024
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 Aug 2024
EPS came in at -$1.60 falling short of the estimated -$0.16 by -900.00%.
Earnings released on 21 May 2024
EPS came in at -$3.00 matching the estimated -$3.00.
Earnings released on 5 Mar 2024
EPS came in at -$6.40 falling short of the estimated -$3.40 by -88.24%.
Earnings released on 21 Nov 2023
EPS came in at -$4.20 surpassing the estimated -$4.40 by +4.55%.
Earnings released on 22 Aug 2023
EPS came in at -$4.60 surpassing the estimated -$5.00 by +8.00%.
Earnings released on 16 May 2023
EPS came in at -$4.20 surpassing the estimated -$7.00 by +40.00%.
Earnings released on 8 Feb 2023
EPS came in at -$6.00 matching the estimated -$6.00.
Earnings released on 8 Nov 2022
EPS came in at -$0.27 falling short of the estimated -$0.21 by -28.57%.
Earnings released on 4 Aug 2022
EPS came in at -$0.20 .
Earnings released on 12 May 2022
EPS came in at -$0.41 .
Earnings released on 1 Mar 2022
EPS came in at -$0.29 .
Earnings released on 9 Feb 2022
EPS came in at -$0.18 .
Earnings released on 5 Aug 2021
EPS came in at -$0.38 falling short of the estimated -$0.01 by -3.67K%.
Earnings released on 30 Jun 2021
EPS came in at -$0.21 .
Earnings released on 2 Mar 2021
EPS came in at -$0.01 surpassing the estimated -$0.01 by +35.30%.
Earnings released on 31 Dec 2020
EPS came in at -$0.04 .
PPBT Stock Performance
Access detailed PPBT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.